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ABSTRACT 
 
Humans are exposed to many chemicals via intake of food and drink and there are 
strong associations between dietary factors and cancer. Exposure to the dietary 
carcinogens acrylamide and acetaldehyde are potential health risks that have made the 
headlines. High levels of acrylamide are found in various food items, such as potato 
chips. Acetaldehyde exposure in association with alcoholic beverages is clearly linked to 
increased cancer risk. In addition, acetaldehyde is a contaminant and present or produced 
in various foods, including certain dairy products.  
Dietary exposure is normally assessed from levels in food together with consumption 
patterns. However, with such assessments it is difficult to take into account the 
metabolic changes to the various chemicals, as the interindividual variations are great. 
Efforts have therefore been made to improve measurements of internal exposure by use 
of biomarkers, such as DNA adducts. 
The aim of this thesis was to develop and apply biomarkers for human exposure to 
acrylamide and acetaldehyde. This was done by characterizing the DNA adduct N1-(2-
carboxy-2-hydroxyethyl)deoxyadenosine (N1-GA-dA), formed by glycidamide) and the 
adducts N2-ethyl-2’-deoxyguanosine (N2-ethyl-dG) and N6-ethyl-2'-deoxyadenosine (N6-
ethyl-dG), both formed by acetaldehyde. In addition, LC-MS/MS and 32P-postlabeling 
methods for the analysis of these DNA adducts were developed and used to analyze 
animal and human DNA and tissue samples.  
The glycidamide-derived DNA adduct N1-GA-dA was for the first time shown to be 
formed when mammalian cells were treated with glycidamide. However, the adduct was 
not detected in liver DNA of mice exposed to acrylamide. 
The adduct N2-ethyl-dG was detected in DNA treated in vitro with acetaldehyde, in 
human lung DNA from smokers and non-smokers and for the first time in DNA exposed 
in vitro to cannabis smoke. N2-Ethyl-dG was also analyzed in leukocyte DNA from a 
group of healthy men who had consumed a moderate amount of alcohol under controlled 
circumstances. Adduct levels were not significantly increased. The chemical stability of 
N2-ethyl-dG was studied and the findings imply that the rate of loss is more rapid than 
previously thought.  
With the 32P-postlabeling assay developed for the analysis of acetaldehyde adducts, it 
was shown for the first time that N6-ethyl-dA is formed in DNA in vitro exposed to 
acetaldehyde.  
Sensitive biomonitoring methods were developed and several novel findings were 
made. The methods used could be applied in future animal and human studies of 
exposure to glycidamide and acetaldehyde. In order to make these biomarkers useful for 
epidemiological studies, they must be fully validated and future biomarker studies 
should aim for analysis of multiple endpoints in a large number of samples.  
 
ISBN 978-91-7549-308-4 
 
